XP
Xeris Pharmaceuticals Inc
🇺🇸XNAS.XERSUnited StatesHealthcare
$7.80USDup +0.31 (+4.14%)ClosedDelayed12:49 PM
Price$7.80+0.31 (+4.14%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US98422E1038
- CUSIP
- 98422L107
Company
- Employees
- 435
- Headquarters
- Chicago, United States
- Website
- https://www.xerispharma.com
- CEO
- Mr. John P. Shannon
Market
- Shares outstanding
- 182.3M
- Market cap
- $1.42B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $1.42B
- EPS LTM
- -$0.10
- P/E LTM
- -79.74
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $335.41M+36.33%up year on year
- Net income
- -$17.17M+46.36%up year on year
- Gross margin
- 83.34%+2.72%up year on year
- Free cash flow
- $55.38M+430.06%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.